Sfoglia per Rivista  HEPATOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 56 a 75 di 186
Titolo Data di pubblicazione Autore(i) File
HBV cccDNA evaluation in HBV-core antibody (HBcAb)-positive liver transplant donors 2015 Caviglia, Gp; Tandoi, F; Abate, Ml; Ciancio, A; Romagnoli, R; Smedile, A
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. 2000 DEFRANCESCHI L; FATTOVICH G; F. TURRINI; AYI K; BRUGNARA C; MANZATO F; NOVENTA F; STANZIAL AM; SOLERO P; CORROCHER R
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause? 2013 van der Poorten D;Samer CF;Ramezani-Moghadam M;Coulter S;Kacevska M;Schrijnders D;Wu LE;McLeod D;Bugianesi E;Komuta M;Roskams T;Liddle C;Hebbard L;George J
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease 2016 Rosso, C.; Kazankov, K.; Marietti, M.; Gaggini, M.; Buzzigoli, E.; Møller, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; Gastaldelli, A.; George, J.; Grønbæk, H.; Bugianesi, E.
Hepatic Surgeons Are Like the Child Who Rescued Dying Fish: REPLY 2016 Romagnoli Renato; Mazzaferro Vincenzo; Bruix Jordi
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. 2001 PERSICO M; PERSICO E; BAKKER CTN; RIGATO I; A. AMOROSO; TORELLA R; BOSMA PJ; TIRIBELLI C; OSTROW JD
Hepatitis B Core-Related Antigen is a Better Marker Than HBsAg for Discriminating between Chronic HBV Infection and Chronic Hepatitis B in a HBeAg-negative European Cohort 2018 Mauriza R Brunetto, Ivana Carey, Benjamin Massoumy, Cristina Marcos, Gijs Van Halewijn, Gian Paolo Caviglia, Alessandro Loglio, Daniela Cavallone, Caroline Scholtes, Antonina Smedile, Mar Riveiro-Barciela, Florian Van Bommel, Annemiek Van Der Eijk, Fabien Zoulim, Thomas Berg, Markus Cornberg, Pietro Lampertico, Kosh Agarwal, Maria Buti
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. 1991 SMEDILE A ;ROSINA F ;SARACCO G ;CHIABERGE E ;LATTORE V ;FABIANO A ;BRUNETTO MR ;VERME G ;RIZZETTO M ;BONINO F
Hepatitis C virus antibodies associated hepatocellular carcinoma. 1992 LM Fenoglio; GM Peano; G Menardi; A Veltri; D Regge; L Ghezzo; S Fenoglio; GF Ferro
Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope 1998 SMEDILE A; CASEY J.L; COTE P.J; M. DURAZZO; LAVEZZO B; PURCELL R.H; RIZZETTO M; GERIN J.L
Hepatitis delta in Europe: vanishing or refreshing? 2007 Giovanni B Gaeta; Tommaso Stroffolini; Antonina Smedile; Grazia Niro; Alfonso Mele
Hepatocytes release microparticles during lipotoxicity that have potent pro-angiogenic effects in vitro and in vivo through Vanin-1-dependent internalization. 2012 Povero D; Eguchi A; Lazic M; Johnson C; Parola M; Feldstein A.
Hepatocytes-derived microparticles released during lypotoxicity induced hepatic stellate cells activation and migration 2013 Davide Povero; Akiko Eguchi; Chiara Busletta; Erica Novo; Maurizio Parola; Ariel E. Feldstein
HIGH MELD vs HIGH DONOR AGE in liver tx. Who is the winner ? Evidences from the US-ITALY D-MELD study 2013 Avolio, Alfonso W.; Burra, Patrizia; Mariano, Germano; Chang, David; Cillo, Umberto; Cucchetti, Alessandro; Romagnoli, Renato; Humar, Abhinav; Spada, Marco; Melcher, Marc L.; De Carlis, Luciano; Colledan, Michele; Mazzaferro, Vincenzo; Caccamo, Lucio; Lai, Quirino; Calise, Fulvio; Agnes, Salvatore; Halldorson, Jeffrey B.
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials 2012 Patrick Marcellin;Hugo Cheinquer;Manuela Curescu;Geoffrey M. Dusheiko;Peter Ferenci;Andrzej Horban;Donald Jensen;Gabriella Lengyel;Alessandra Mangia;Denis Ouzan;Massimo Puoti;Maribel Rodriguez-Torres;Mitchell L. Shiffman;Manuela Schmitz;Fernando Tatsch;Mario Rizzetto
HLA‐DR Antigens in HBsAg‐Positive Chronic Active Liver Disease with and without Associated Delta Infection 1984 Forzani B.; Actis G.C.; Verme G.; Amoroso A.; Borelli I.; Curtoni E.S.; Rumi M.G.; Picciotto A.; Marinucci G.; Freni M.A.; Rizzetto M.
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. 2010 Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP.
Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. 1995 Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F; Tovo PA
Human liver stem cells improve liver injury in a model of fulminant liver failure. 2013 Herrera Sanchez MB; Fonsato V; Bruno S; Grange C; Gilbo N; Romagnoli R; Tetta C; Camussi G.
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 2018 Morello, E; Sutti, S; Foglia, B; Novo, E; Cannito, S; Bocca, C; Rajsky, M; Bruzzì, S; Abate, Ml; Rosso, C; Bozzola, C; David, E; Bugianesi, E; Albano, E; Parola, M.
Mostrati risultati da 56 a 75 di 186
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile